Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONTROL BIONICS LIMITED Capital/Financing Update 2023

Oct 29, 2023

64611_rns_2023-10-29_c8d318c6-844e-4174-926f-0b78d8496cc1.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

CONTROL BIONICS LIMITED

Announcement Type

New announcement

Date of this announcement

30/10/2023

The Proposed issue is:

==> picture [8 x 8] intentionally omitted <==

A standard pro rata issue (including non-renounceable or renounceable)

Total number of +securities proposed to be issued for a standard pro rata issue (including non-renounceable or renounceable)

Maximum Number of
ASX +security code +Security description +securities to be issued
CBL ORDINARY FULLY PAID 68,272,612

Ex date

1/11/2023

+Record date

2/11/2023

Offer closing date

24/11/2023

Issue date

29/11/2023

Refer to next page for full details of the announcement

Proposed issue of securities

1 / 7

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of +Entity

CONTROL BIONICS LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.2 Registered Number Type Registration Number ABN 45115465462

1.3 ASX issuer code

CBL

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

30/10/2023

1.6 The Proposed issue is:

==> picture [8 x 8] intentionally omitted <==

A standard +pro rata issue (non-renounceable or renounceable)

1.6a The proposed standard +pro rata issue is:

==> picture [8 x 8] intentionally omitted <==

  • Non-renounceable

Proposed issue of securities

2 / 7

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

Part 3 - Details of proposed entitlement offer issue

Part 3A - Conditions

3A.1 Do any external approvals need to be obtained or other conditions satisfied before the entitlement offer can proceed on an unconditional basis? No

Part 3B - Offer details

Class or classes of +securities that will participate in the proposed issue and class or classes of +securities proposed to be issued

ASX +security code and description

CBL : ORDINARY FULLY PAID

Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? Existing class

Will the proposed issue of this If the entity has quoted company +security include an offer of options, do the terms entitle option attaching +securities? holders to participate on exercise? No No

Details of +securities proposed to be issued

ASX +security code and description

CBL : ORDINARY FULLY PAID

ISIN Code (if Issuer is a foreign company and +securities are non CDIs)

ISIN Code for the entitlement or right to participate in a non-renounceable issue (if Issuer is foreign company and +securities are non CDIs)

Offer ratio (ratio to existing holdings at which the proposed +securities will be issued)

The quantity of additional +securities For a given quantity of +securities to be issued held

2 3

Proposed issue of securities

3 / 7

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

What will be done with fractional Maximum number of +securities entitlements? proposed to be issued (subject to rounding) Fractions rounded up to the next 68,272,612 whole number

Offer price details for retail security holders

In what currency will the offer be What is the offer price per +security made? for the retail offer? AUD - Australian Dollar AUD 0.04000

Oversubscription & Scale back details

Will individual +security holders be permitted to apply for more than their entitlement (i.e. to over-subscribe)?

==> picture [9 x 8] intentionally omitted <==

Yes

Describe the limits on over-subscription

The allocation of Additional New Shares will be subject to availability of Additional New Shares and will occur in the Company's absolute discretion .

Will a scale back be applied if the offer is over-subscribed?

==> picture [9 x 9] intentionally omitted <==

Yes

Describe the scale back arrangements

Any scale back will be subject to availability of Additional New Shares and will occur in the Company's absolute discretion

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class?

==> picture [9 x 8] intentionally omitted <==

Yes

Part 3C - Timetable

3C.1 +Record date

2/11/2023

3C.2 Ex date

1/11/2023

Proposed issue of securities

4 / 7

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

3C.4 Record date 2/11/2023 3C.5 Date on which offer documents will be sent to +security holders entitled to participate in the +pro rata issue 7/11/2023 3C.6 Offer closing date 24/11/2023 3C.7 Last day to extend the offer closing date 21/11/2023 3C.9 Trading in new +securities commences on a deferred settlement basis 27/11/2023 3C.11 +Issue date and last day for entity to announce results of +pro rata issue 29/11/2023 3C.12 Date trading starts on a normal T+2 basis 30/11/2023 3C.13 First settlement date of trades conducted on a +deferred settlement basis and on a normal T+2 basis 4/12/2023

Part 3E - Fees and expenses

3E.1 Will there be a lead manager or broker to the proposed offer? No

3E.2 Is the proposed offer to be underwritten? Yes

3E.2a Who are the underwriter(s)?

Nightingale Partners Pty Limited ($500,000), Phoenix Development Fund Limited ($500,000), Directors who are underwriting and the amount of the underwriting are: -Roger Hawke $4,143 -Jeremy Steele $33,838 - Damian Lismore $20,111 - Robert Heard $18,939

3E.2b What is the extent of the underwriting (ie the amount or proportion of the offer that is underwritten)? $1,077,032

3E.2c What fees, commissions or other consideration are payable to them for acting as underwriter(s)?

5% of the amount underwritten

Proposed issue of securities

5 / 7

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

3E.2d Please provide a summary of the significant events that could lead to the underwriting being terminated

-the Offer Document is withdrawn

  • -ASIC takes any regulatory action in connection with the Offer;

  • -the Company is prevented from issuing the Shares within the time required by the Agreement -the Company fails to lodge an Appendix 3B; or

  • -any date in the Timetable is not met for more than five (5) Business Days.

3E.2e Is a party referred to in listing rule 10.11 underwriting or sub-underwriting the proposed offer? Yes

3E.2e (i) What is the name of that party?

Roger Hawke Jeremy Steele Damian Lismore Robert Heard

3E.2e (ii) What is the extent of their underwriting or sub-underwriting (ie the amount or proportion of the offer they have underwritten or sub-underwritten)?

$77,032

3E.2e (iii) What fee, commission or other consideration is payable to them for acting as underwriter or sub-underwriter?

5% of the amount underwritten

3E.3 Will brokers who lodge acceptances or renunciations on behalf of eligible +security holders be paid a handling fee or commission? No

3E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed offer

Part 3F - Further Information

3F.1 The purpose(s) for which the entity intends to use the cash raised by the proposed issue

See ASX announcement 30 October 2023

3F.2 Will holdings on different registers or subregisters be aggregated for the purposes of determining entitlements to the issue? No

3F.3 Will the entity be changing its dividend/distribution policy if the proposed issue is successful? No

3F.4 Countries in which the entity has +security holders who will not be eligible to participate in the proposed issue

HK, Singapore, UK, USA

3F.5 Will the offer be made to eligible beneficiaries on whose behalf eligible nominees or custodians hold existing +securities

==> picture [8 x 8] intentionally omitted <==

Yes

Proposed issue of securities

6 / 7

Proposed issue of securities

==> picture [21 x 22] intentionally omitted <==

3F.5a Please provide further details of the offer to eligible beneficiaries

Eligible Shareholders who are nominees, trustees or custodians are advised to seek independent advice as to how to proceed. The Offer is being made to all Eligible Shareholders. The Company is not required to determine whether or not any Eligible Shareholder is acting as a nominee or the identity or residence of any underlying beneficial owners of Shares.

3F.6 URL on the entity's website where investors can download information about the proposed issue

3F.7 Any other information the entity wishes to provide about the proposed issue

3F.8 Will the offer of rights under the rights issue be made under a disclosure document or product disclosure statement under Chapter 6D or Part 7.9 of the Corporations Act (as applicable)? No

3F.9 Any on-sale of the +securities proposed to be issued within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)

Proposed issue of securities

7 / 7